The prognostic value of microfluidic core technology in detecting circulating tumor cells in brain glioma

杨通衢; 韩志桐; 赵卫平; 陈云照; 张大鹏; 张瑞剑

doi:10.19401/j.cnki.1007-3639.2021.10.005

您当前的位置：

首页 >

文章列表页 >

The prognostic value of microfluidic core technology in detecting circulating tumor cells in brain glioma

更新时间：2025-12-31

- The prognostic value of microfluidic core technology in detecting circulating tumor cells in brain glioma
- China Oncology Vol. 31, Issue 10, Pages: 905-911(2021)
- 作者机构：
  
  1. 内蒙古医科大学附属医院,内蒙古,呼和浩特,010010
  2. 内蒙古自治区人民医院神经外科,内蒙古,呼和浩特,010010
  3. 内蒙古科技大学包头医学院,内蒙古,包头,014040
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2021.10.005
  CLC：
- Published Online：09 November 2021，
  
  Published：09 November 2021
- 稿件说明：
移动端阅览
杨通衢, 韩志桐, 赵卫平, 陈云照, 张大鹏, 张瑞剑 . 微流控芯技术检测循环肿瘤细胞在脑胶质瘤预后预测中的价值[J]. 中国癌症杂志, 2021, 31(10): 905-911.

杨通衢, 韩志桐, 赵卫平, et al. The prognostic value of microfluidic core technology in detecting circulating tumor cells in brain glioma[J]. China Oncology, 2021, 31(10): 905-911.
杨通衢, 韩志桐, 赵卫平, 陈云照, 张大鹏, 张瑞剑 . 微流控芯技术检测循环肿瘤细胞在脑胶质瘤预后预测中的价值[J]. 中国癌症杂志, 2021, 31(10): 905-911. DOI： 10.19401/j.cnki.1007-3639.2021.10.005.

杨通衢, 韩志桐, 赵卫平, et al. The prognostic value of microfluidic core technology in detecting circulating tumor cells in brain glioma[J]. China Oncology, 2021, 31(10): 905-911. DOI： 10.19401/j.cnki.1007-3639.2021.10.005.

摘要

背景与目的：脑胶质瘤患者的预后既往多通过生化指标进行预测，临床实践中有一定难度且受多种因素影响，导致预测效率相对较差。探讨微流控芯技术检测循环肿瘤细胞（circulating tumor cell，CTC）在脑胶质瘤预后预测中的价值。方法：选取2016年3月—2020年3月内蒙古自治区人民医院神经外科收治的96例脑胶质瘤患者为研究对象，采用微流控芯技术富集患者外周血CTC，并利用免疫荧光法对CTC进行鉴定；采用logistic回归方程分析脑胶质瘤患者外周血CTC的检测结果与脑胶质瘤临床特征之间的关系并建立受试者工作特征（receiver operating characteristic，ROC）曲线；制作并分析脑胶质瘤患者术后生存曲线。结果：微流控芯技术对CTC富集联合免疫荧光结果显示，CTC检测阳性率为42.71%，外周血检测出的CTC数目为（66.27±6.36）/mL；单因素分析结果显示，外周血CTC与患者的肿瘤分期、组织学类型、淋巴结转移是否存在囊性病变、神经元特异性烯醇化酶（neuron-specific enolase，NSE）密切相关（P0.05），与年龄、性别、KPS评分、血清胶质纤维酸性蛋白（glial fibrillary acidic protein，GFAP）含量等临床特征无相关性；多因素分析结果显示肿瘤分期、组织学类型及NSE的表达与CTC密切相关；通过ROC曲线分析得出肿瘤分期、组织学类型以及NSE的AUC分别为0.645、0.687、0.720，预测概率AUC为0.814（P0.05）；CTC阳性组和阴性组患者1年生存率差异无统计学意义（P0.05），但两组患者2年和3年生存率差异有统计学意义（P0.05）。结论：微流控芯技术可定量检测脑胶质瘤患者外周血CTC，其水平与肿瘤分期、组织学类型、NSE密切相关，直接影响脑胶质瘤患者远期生存率。因此，外周血CTC可作为脑胶质瘤患者预后预测的重要指标。

Abstract

Background and purpose: IIn the past

the prognosis of glioma was mainly predicted by biochemical indicators. In clinical practice

it is difficult to predict the prognosis of glioma due to the contamination of various factors

which leads to relatively poor prediction efficiency. This study aimed to investigate the value of circulating tumor cells (CTCs) by microfluidic core in the diagnosis and prognosis of gliomas. Methods: A total of 96 patients with brain glioma admitted to the Department of Neurosurgery in People's Hospital of Inner Mongolia Autonomous Region from March 2016 to March 2020 were studied. CTCs were enriched in peripheral blood by microfluidic core technology

and identified by immunofluorescence method. The regression model was used to analyze the relationship between the detection of CTCs in peripheral blood of glioma patients and the clinical characteristics of glioma patients. The receiver operating characteristic (ROC) curve was established

and the survival curve was made to analyze CTCs test results and the postoperative survival time of glioma patients. Results: CTCs enrichment by microfluidic core technology combined with immunofluorescence showed CTCs with a positive detection rate of 42.71%

and the number of CTCs detected in peripheral blood was (66.27±6.36)/mL. Univariate analysis showed that CTC in peripheral blood was closely correlated to tumor stage

histological type

cystic lymph node metastasis and neuron-specific enolase (NSE) (P0.05)

but had no correlation with age

gender

smoking status Cartesian functional status score

glial fibrillary acidic protein (GFAP) content and other clinical characteristics. Multivariate analysis showed that tumor stage

histological type

NSE expression and CTCs were closely related. The area under the curve (AUC) of tumor stage

histological type and NSE were 0.645

0.687 and 0.720

respectively

and the predictive probability AUC was 0.814 (P0.05). The CTCs test results and the postoperative survival curve of glioma patients were analyzed. Conclusion: The microfluidic core technology established in this study can quantitatively detect peripheral blood CTCs in patients with glioma

whose CTCs level is closely related to tumor stage

histological type and NSE

and directly affects the long-term survival rate of patients with glioma. Therefore

peripheral blood CTCs can be used as an important indicator for the diagnosis and prognosis of glioma patients

providing a new idea for clinical research.

关键词

Keywords

references

Views

2080

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Retrospective study on MGMT methylation status and its clinical significance in gliomas

Expression difference and clinical significance of CHKα in different grades of gliomas

Clinicopathologic features of SMARCA4-deficient pulmonary malignant tumor with an emphasis on the prognosis

Treatment strategies and prognostic analysis of 87 patients with salivary duct carcinoma: a retrospective cohort study

Research progress and prospects on the mechanisms of circulating tumor cells in the invasion and metastasis of cholangiocarcinoma

Related Author

Lin JIANG

Qiying LIU

Liqing JIA

Jing ZHANG

Heng CHANG

Tian XUE

Min REN

Qianming BAI

Related Institution

Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Fudan University Cancer Institute

宁夏医科大学临床医学院

宁夏医科大学总医院神经外科

Department of Pathology, Wuxi Second People’s Hospital

Department of Pathology, Affiliated Hospital of Nantong University

AI问答

⁰